Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Hold
2,082
0.13% 73
2026
Q1
$250K Buy
2,082
+1
+0% +$115 0.14% 72
2025
Q4
$219K Buy
+2,081
New +$195K 0.12% 79
2025
Q3
Sell
-3,097
Closed -$245K 94
2025
Q2
$245K Hold
3,097
0.17% 76
2025
Q1
$278K Sell
3,097
-108
-3% -$10.1K 0.23% 65
2024
Q4
$319K Hold
3,205
0.23% 53
2024
Q3
$364K Buy
3,205
+1
+0% +$119 0.27% 53
2024
Q2
$397K Buy
3,204
+109
+4% +$14K 0.31% 50
2024
Q1
$408K Buy
3,095
+166
+6% +$20.5K 0.34% 52
2023
Q4
$319K Buy
+2,929
New +$304K 0.29% 62

Other funds holding MRK

Gerber LLC's MRK Position: Q2 2026 in Review

Gerber LLC held its Merck (MRK) position steady in Q2 2026 at 2,082 shares worth $268K. The position accounts for 0.13% of the portfolio, ranked #73.

Gerber LLC first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $408K in Q1 2024. 2,083 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gerber LLC held 2,082 shares of Merck worth $268K as of Q2 2026.
  • Gerber LLC left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.13% of Gerber LLC's portfolio in Q2 2026, its #73 holding.
  • Gerber LLC first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Gerber LLC's Merck position peaked at $408K in Q1 2024.
  • 2,083 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gerber LLC's 13F filing for Q2 2026, filed 29 Jul 2026.